INDs for PET Molecular Imaging Probes—Approach by an Academic Institution

We have developed an efficient, streamlined, cost-effective approach to obtain Investigational New Drug (IND) approvals from the Food and Drug Administration (FDA) for positron emission tomography (PET) imaging probes (while the FDA uses the terminology PET drugs, we are using “PET imaging probes,”...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosessian, Sherly, Duarte-Vogel, Sandra M., Stout, David B., Roos, Kenneth P., Lawson, Gregory W., Jordan, Maria C., Ogden, Amanda, Matter, Cheryl, Sadeghi, Saman, Mills, George Q., Schelbert, Heinrich R., Radu, Caius G., Czernin, Johannes, Couto, Marcelo, Phelps, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Special Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097325/
https://www.ncbi.nlm.nih.gov/pubmed/24733693
http://dx.doi.org/10.1007/s11307-014-0735-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097325/
https://www.ncbi.nlm.nih.gov/pubmed/24733693
http://dx.doi.org/10.1007/s11307-014-0735-2

Ejemplares similares